Certolizumab Pegol treatment in Behcet's disease with different organ involvement: A multicenter retrospective observational study.

about

Certolizumab Pegol treatment in Behcet's disease with different organ involvement: A multicenter retrospective observational study.

Item

http://www.wikidata.org/entity/Q38677010

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Certolizumab Pegol treatment i ...... ospective observational study.

@en

type

Item

label

Certolizumab Pegol treatment i ...... ospective observational study.

@en

prefLabel

Certolizumab Pegol treatment i ...... ospective observational study.

@en

P1476

Certolizumab Pegol treatment i ...... rospective observational study

@en

P2093

Antonio Vitale

http://www.w3.org/2001/XMLSchema#string

Bruno Frediani

http://www.w3.org/2001/XMLSchema#string

Elena Silvestri

http://www.w3.org/2001/XMLSchema#string

Giuseppe Lopalco

http://www.w3.org/2001/XMLSchema#string

Iacopo Cavallo

http://www.w3.org/2001/XMLSchema#string

Stefano Gentileschi

http://www.w3.org/2001/XMLSchema#string

P2860

Mucocutaneous Involvement in Behçet's Disease: How Systemic Treatment Has Changed in the Last Decades and Future Perspectives

Infliximab for the treatment of Neuro-Behçet's disease: a case series and review of the literature.

EULAR recommendations for the management of Behçet disease.

Golimumab as rescue therapy for refractory immune-mediated uveitis: a three-center experience.

Anti-TNF agents for Behçet's disease: analysis of published data on 369 patients.

Putative Role of Serum Amyloid-A and Proinflammatory Cytokines as Biomarkers for Behcet's Disease.

Behçet's syndrome: disease manifestations, management, and advances in treatment.

Infliximab therapy for intestinal, neurological, and vascular involvement in Behcet disease: Efficacy, safety, and pharmacokinetics in a multicenter, prospective, open-label, single-arm phase 3 study.

Evaluation of current therapeutic strategies in Behçet's disease.

Adalimumab for the treatment of Behçet's disease: experience in 19 patients.

P304

1031-1035

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14397595.2017.1285857

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-02-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28712320

http://www.w3.org/2001/XMLSchema#string

P921

multicenter trial

Behcet's disease